Clinical Study of Trancatheter Closure of Patent Ductus Arteriosus with Occluder Device
Lifang Yang,Shiqiang Yu,Jincheng Liu,J. Zuo,Wensheng Chen,W. Duan,Qijun Zheng,Xuezeng Xu,Jun Li,Jun Zhang,Jian Xu,Lijun Sun,Xiuling Yang
2016-01-01
Abstract:Objective To evaluate the efficiency of transcatheter closure of patent ductus arteriosus (PDA) using occluder device. Method 25 patients with PDA were treated with transcatheter closure with duct occluder device. Each PDA was occluded through the percutaneous procedure. Aortographies were made to evaluate the efficiency immediately after the procedure. Echocardiographies were performed 72 hours, 1 month and 3 month after the closure to find whether there was a residual shunt or recanalization. Results The smallest diameter of PDA measured by aortography was 5.9±1.2 (1.5-11)mm, and the mean diameter of duct occluder device measured by aortography was 11.8±1.5 (6-16)mm. The technical successful rate was 100%. Aortography showed that 25 patients had been completely closed 10 minutes after operation, the mean pressure of pulmonary artery declined significantly after operation (P < 0.05). No complications happened during operation. Residual shunt, the place of duct occluder device, hemolysis, embolism and aortic stenosis didn’t happen during 3 months follow-up. Conclusion Transcatheter closure of PDA using duct occluder device is safe and efficient. The success rate if high, and there is less trauma. • SHSMA Corporation, Shanghai, China, Occluders and Vascular Plugs have been CE-Certified by Comed BV, The Netherlands under CE0535., as HyperionTM Occluders and Vascular Plugs. Hyperion is a trademark of Comed BV, The Netherlands. Comed Clinical Information HyperionTM Occluders & Vascular Plugs info@comedbv.com / www.comedbv.com Safety and Efficacy of Transcatheter Closure of Large Atrial Septal Defect Huang Guoming1, Ding Zhongru1, Tu Xiaowen1, Qiao Huaiyu1, Wang Hongru1, Yu Yanli1, Han Qingping1, Wen Ping2. 1.Department of Cardiology, 2. Department of Ultrasound Diagnosis, The 94th Hospital of PLA, Nanchang, Jiangxi 330002, China International Journal of Cardiovascular Disease 2008, 35 (3). Objective This study was to evaluate the safety and efficacy of transcatheter closure of large atrial septal, by analyzing the treatment of 12 cases of ASD defined as > 30mm in diameter. Method Twelve patients with secondary LASD (Sex: 5 male and 7 female; age 36.3±10.6) years old; ASD diameter: (33.1±4.5) mm; 4 with stump of top atrium cordis < 3 mm; 3 with stump AO < 3 mm or absence; PAMP: (36.2±13.1) mmHg, 7 with moderate pulmonary hypertension or worse; 6 with heart enlargement in X-Ray check, accepted interventional therapy with Chinese-made occluder devices (diameter: 36~42mm), and were assessed with ECG, transthoracic echocardiography (TTE) and X-Ray check before and after the procedure at the follow-up of 1 week, 3 month, 6 month and 1 year. Results In 12 patients treated by methods of right superior pulmonary vein release, LASDs were successfully closed in 10 patients (83.3%). Immediate residual shunt was found in 2 patients and vanished in one week. Device dislocation occurred in one case with stump of top atrium cordis < 3 mm and emergency surgical intervention was conducted. No death cases. Pulmonary pressure decreased obviously after device implantation in 5 cases with moderate pulmonary hypertension, and hearts deflated in 6 heart-enlarged cases. No split stream occurred on atrium cordis level. No other complications such as embolization, infective endocarditis, cardiac perforation, Purkinje system abnormality and migraine was observed. Conclusion Transcatheter closure of large atrial septum defect with Chinese-made occluder device is safe and efficiency, so long as the indications and monitoring after procedure are in attention. • SHSMA Corporation, Shanghai, China, Occluders and Vascular Plugs have been CE-Certified by Comed BV, The Netherlands under CE0535., as HyperionTM Occluders and Vascular Plugs. Hyperion is a trademark of Comed BV, The Netherlands. Comed Clinical Information HyperionTM Occluders & Vascular Plugs info@comedbv.com / www.comedbv.com Simultaneous transcatheter therapy of perimembranous ventricular septal defect combined with atrial septal defect. Zhao Xian-xian, Qin Yongwen, Xiong Wenfeng, et al. Department of Cardilogy, Changhai Hospital, Second Military Medical University, Shanghai 200433, China. Interventional Radilogy 2004, Vol. 13, No 2. Objective To evaluate the possibility, methods and efficiency of simultaneous transcatheter therapy of perimembranous ventricular septal defect (VSD) combined with atrial septal defect (ASD). Method Four patients with PM VSD combined with ASD, including 3 males and 1 female, age ranging from 12 to 16 years; underwent simultaneous attempted transcatheter therapy. The diameter of PM VSD were 3-6 mm and the distances from the defect rim to aortic valve were 2-6 mm by echocardiography before the procedure, the stretched diameter of ASD was 6-10 mm. PM VSD were occluded using homemade (Chinese) two disc PM VSD occluder first and the ASD were occluded later on. Report All patients were treated successfully at one time. The diameter of ASD was 6-10 mm and the occluder diameter was 6-12 mm. No residual shunt was found by the transthoracic echocardiography and left ventriculography after the occluders deployed. No complications occurred. Conclusion Simultaneous transcatheter therapy of PMVSD combined with ASD is feasible, safe and effective. • SHSMA Corporation, Shanghai, China, Occluders and Vascular Plugs have been CE-Certified by Comed BV, The Netherlands under CE0535., as HyperionTM Occluders and Vascular Plugs. Hyperion is a trademark of Comed BV, The Netherlands. Comed Clinical Information HyperionTM Occluders & Vascular Plugs info@comedbv.com / www.comedbv.com Transcatheter closure with use of the SHSMA occluder in 180 patients with congenital heart defects; preliminary results. Wang-Feng Sun, Zhi-Feng Dong, Kaizheng Gong, Guo-Pei Zhang, Ting Cui, Yu-Dong Xia, Jing Dong, Yuan Shen. Tex Heart Inst J 2010 ; 37(5):531-7 Transcatheter closure of congenital heart defects with the use of septal occluders has been widely accepted as a preferred treatment; however, the high cost of these devices limits their clinical application in some countries. Few clinical data are available regarding lower-cost products. Accordingly, we evaluated the efficacy and safety of the Chinese-made Shanghai Shape Memory Alloy (SHSMA) occluder in patients with congenital heart defects. From December 2001 through December 2008, a total of 180 patients with congenital heart defects (ages, 3– 68 yr; mean age, 17.35 ± 13.22 yr) underwent transcatheter closure with use of the SHSMA occluder: 73 had atrial septal defects; 64, ventricular septal defects; 40, patent ductus arteriosus; and 3, complex congenital defects. The mean diameters of the defects were 20 ± 7.6 mm (atrial septal), 4.9 ± 2.1 mm (ventricular septal), and 5.6 ± 2.2 mm (patent ductus arteriosus). The procedural success rates were 98.6% for atrial defects, 98.4% for ventricular defects, and 100% for patent ductus arteriosus and for complex defects. The overall incidences of sequelae were 5.5%, 9.4%, 2.5%, and 0, respectively. Six months postprocedurally, complete occlusion was associated with a significant decrease in the right ventricular Tei index in atrial septal defect patients (P <0.05) and with improvement of body mass index in 11 children. These results suggest that the SHSMA occluder is a safe, effective device for the transcatheter closure of congenital heart defects. For confirmation, a randomized controlled trial with more patients and a longer follow-up period is warranted. • SHSMA Corporation, Shanghai, China, Occluders and Vascular Plugs have been CE-Certified by Comed BV, The Netherlands under CE0535., as HyperionTM Occluders and Vascular Plugs. Hyperion is a trademark of Comed BV, The Netherlands. Comed Clinical Information HyperionTM Occluders & Vascular Plugs info@comedbv.com / www.comedbv.com Transcatheter closure of multi-hole perimembranous VSD with aneurysm: 3-year follow-up study. Wu H1, Qin Y, Zhao X, Hu J, Zheng X, Wang E, Li W, Wang Y, Liu B, Liu J, Wang S. Clin Res Cardiol. 2009 Sep;98(9):563-9. doi: 10.1007/s00392-009-0044-y. Epub 2009 Jul 10. Abstract The majority of ventricular septal defects (VSDs) are perimembranous, accounting for 75-80% of all VSDs.The majority of ventricular septal defects (VSDs) are perimembranous, accounting for 75-80% of all VSDs. The objective of this study was to investigate occluder selection and transcatheter closure technique for multi-hole perimembranous VSD with aneurysm, and to evaluate clinical efficacy and safety. Patients with multi-hole VSDs and aneurysm (n = 64) were selected for the procedure using transthoracic echocardiography. Double-disc symmetrical, small-waist double-disc asymmetrical and zero eccentricity occluders were selected based on left ventricular angiography. The closure was successful in 63 of 64 patients (98%). The double-disc symmetrical occluder was used in 16 cases, the small-waist double-disc asymmetrical occluder in 42 cases, and the zero eccentricity occluder in 8 cases (2 occluder types were used in 2 cases). Fifteen minutes after the procedure, 52 cases had no residual shunt and 12 had a trace amount of residual shunt. The residual shunt disappeared in five cases 5-7 days post procedure, with a trace amount of shunt remaining in seven cases. Transient conduction abnormalities related to the procedure occurred in six patients; however, none required permanent pacemaker implantation. At the 1-month, 6-month, 1-year, 2-year, and 3-year follow-up visits, echocardiography indicated that the position of the occluders was fixed, and there were no complications including residual shunt, newly developed atrioventricular block, thromboembolism, or bacterial endocarditis. The study results indicate that left ventricular angiography is useful in selecting the most appropriate device for transcatheter closure of multi-hole perimembranous VSD with aneurysm. The transcatheter closure procedure is safe and effective with little residual shunt and